• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Arcus Ventures

edit

Arcus Ventures (AV) consists of a team of professionals with experience in clinical and academic medicine, drug development, hospital management, healthcare industry consulting and private equity. AV is dedicated to investing in oncology focused companies with innovative biopharmaceuticals and or new drug delivery platforms in development, device companies with products that have pre-marketing approval, and service companies with positive revenue.

Recent Milestones

edit

• 
  Arcus Ventures invested in Molecular Imaging. (3/7/12)
  Posted 7/29/11 at 2:24am via molecularimaging.com
• 
  Arcus Ventures invested in T2 Biosystems. (8/10/11)
  Posted 8/10/11 at 5:46pm via masshightech.com
• 
  Arcus Ventures invested in MIR Acquisition. (5/9/11)
  Posted 5/9/11 at 7:59pm via finsmes.com
• 
  Arcus Ventures invested in TRACON Pharmaceuticals. (4/20/11)
  Posted 4/20/11 at 10:11pm via traconpharma.com
• 
  Arcus Ventures invested in Vascular Pathways. (11/1/10)
  Posted 11/1/10 at 9:52pm via finsmes.com
• 
  Arcus Ventures invested in T2 Biosystems. (5/26/10)
  Posted 5/26/10 at 5:09pm via onbiovc.com

Investments

Videos

Sources

1. Arcus Ventures Raises $35.6M for Second Health-Care Venture Fund (pevc.dowjones.com) [edit]
2. Molecular Imaging Research, Inc.: Series A $7M (molecularimaging.com) [edit]
3. T2 Biosystems closes $23M Series D financing (masshightech.com) [edit]
4. MIR Acquisition Closes $7M Series A Venture Financing (finsmes.com) [edit]
5. TRACON Pharmaceuticals announces $22 million tranched investment led by JAFCO and Nextech to fund TRC105 Phase 2 development (traconpharma.com) [edit]
6. Vascular Pathways Closes $14M Series B Financing (finsmes.com) [edit]
7. T2 Biosystems, Inc.: Series C $15M (onbiovc.com) [edit]